Dermira (NASDAQ: DERM) reported Q1 EPS of ($0.30), $0.04 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $19.4 million.

For earnings history and earnings-related data on Dermira (DERM) click here.